🇺🇸 FDA
Patent

US 9125922

Phosphate esters of gyrase and topoisomerase inhibitors

granted A61KA61K31/685A61K31/688

Quick answer

US patent 9125922 (Phosphate esters of gyrase and topoisomerase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/685, A61K31/688, A61K45/06, A61P